Fri.May 23, 2025

article thumbnail

Discovery of a Novel Serine-Targeting Covalent Inhibitor against HCES2A for Treating Drug-induced Diarrhea and Ulcerative Colitis

Covalent Modifiers

Danyang Hu, Hairong Zeng, Wenxuan Li, Ya Zhang, Xiaoqian Chi, Xiaoyu Liu, Haijing Zhang, Guangbo Ge, Xiaozhen Jiao, and Ping Xie Journal of Medicinal Chemistry 2025 DOI: 10.1021/acs.jmedchem.5c00563 Mammalian carboxylesterases play an important role in the hydrolysis of both endogenous substrates and xenobiotics bearing ester or amide bond(s). We previously reported that bysspectin A and its derivative LC-20W were potent reversible hCES2A inhibitors.

Drugs 147
article thumbnail

POLB 001: tackling cytokine storms before they start

Drug Target Review

In the ever-evolving landscape of immuno-oncology, managing the side effects of advanced therapies has become just as important as enhancing their efficacy. Among the most concerning complications is cytokine release syndrome (CRS), a potentially life-threatening condition that frequently follows the administration of some CAR T-cell therapies and bispecific antibodies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

White House Report Blames Toxins, Food and Screens for Poor Health

Drugs.com

FRIDAY, May 23, 2025 A new White House report says todays children are the sickest generation in U.S. history when it comes to chronic disease, and it puts the blame on environmental toxins, poor nutrition and too much screen time.Called the "MA.

Disease 162
article thumbnail

Syngeneic Models in Cancer Research: Bridging the Gap Between In Vivo and Clinical Studies

Crown Bioscience

In the evolving landscape of cancer research, the development and validation of effective therapeutic agents depend heavily on preclinical models that can replicate human disease with high fidelity. Among these, syngeneic models have emerged as a vital tool in oncology research, offering a unique balance between experimental control and biological relevance.

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Mystery of 'very odd' elasmosaur finally solved: fiercely predatory marine reptile is new species

Science Daily: Pharmacology News

A group of fossils of elasmosaurs -- some of the most famous in North America -- have just been formally identified as belonging to a 'very odd' new genus of the sea monster, unlike any previously known. This primitive 85-million-year-old, 12 meter-long, fiercely predatory marine reptile is unlike any elasmosaur known to-date and hunted its prey from above.

248
248
article thumbnail

“Radical Transparency” and “Deregulation” from Trump and RFK Jr.’s FDA. Unless it’s Useful to the Device Industry

FDA Law Blog: Biosimilars

By Allyson B. Mullen & Jennifer D. Newberger Last week, FDA published a Request for Information (RFI) ( here ) seeking input from the public on its efforts to to identify and eliminate outdated or unnecessary regulations. The Announcement raises several questions and issues for the device industry. 10-for-1 Rule and its effect on de novos. The RFI reinforces Trumps January 31, 2025 executive order indicating that for every new regulation introduced, at least ten existing regulations must be

FDA 59

More Trending

article thumbnail

Open New Markets: How Biosimilar Clinical Trials Drive Access, Profitability, and Global Expansion …

ProRelix Research

As the patents for blockbuster biologics expire, a new era of opportunity emerges, ushering in the rise of biosimilars. These biologic alternatives offer the promise of affordable care, broader global […] The post Open New Markets: How Biosimilar Clinical Trials Drive Access, Profitability, and Global Expansion … appeared first on ProRelix Research.

article thumbnail

A dental floss that can measure stress

Science Daily: Pharmacology News

Scientists create a floss pick that samples cortisol within saliva as a marker of stress and quantifies it with a built-in electrode. The system uses a polymer casting technology that can be adapted to capture a wide a range of markers, such as estrogen for tracking fertility, or glucose for tracking diabetes. Ease of use allows monitoring to be incorporated into many areas of treatment.

Treatment 257
article thumbnail

Delivering the Future of Radiopharmaceuticals with Precision

Fierce BioTech

Radiopharmaceuticals are transforming modern medicine,while simultaneously intensifying the pressures on pharmaceutical supply chains. | Radiopharma is revolutionizing modern medicine. Discover how precision logistics empowers faster, safer delivery of life-impacting therapies when every second counts.

article thumbnail

Daytime boosts immunity, scientists find

Science Daily: Pharmacology News

Daylight can boost the immune system's ability to fight infections.

172
172
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs

Drugs.com

FRIDAY, May 23, 2025 A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.The U.S. Food and Drug Administration (FDA) already declared that shortages.

FDA 285
article thumbnail

New biosensor solves old quantum riddle

Science Daily: Pharmacology News

Researchers united insights from cellular biology, quantum computing, old-fashioned semiconductors and high-definition TVs to both create a revolutionary new quantum biosensor. In doing so, they shed light on a longstanding mystery in quantum materials.

Research 156
article thumbnail

FDA Approves Nucala for Chronic Obstructive Pulmonary Disease

Drugs.com

FRIDAY, May 23, 2025 -- The U.S. Food and Drug Administration has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD).Nucala stands out as the.

article thumbnail

Controlling quantum motion and hyper-entanglement

Science Daily: Pharmacology News

A new experiment encodes quantum information in the motion of the atoms and creates a state known as hyper-entanglement, in which two or more traits are linked among a pair of atoms.

154
154
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Family Link For Postpartum Psychosis Discovered

Drugs.com

FRIDAY, May 23, 2025 Women are 10 times more likely to develop postpartum psychosis if they have a sister who experienced the condition after an earlier pregnancy, a new study says.Postpartum psychosis is a rare but serious mental illness that c.

230
230
article thumbnail

Earliest use of psychoactive and medicinal plant 'harmal' identified in Iron Age Arabia

Science Daily: Pharmacology News

A new study uses metabolic profiling to uncover ancient knowledge systems behind therapeutic and psychoactive plant use in ancient Arabia.

269
269
article thumbnail

E-Cigarettes Reinforce Nicotine Addiction, Study Says

Drugs.com

FRIDAY, May 23, 2025 Pod-style e-cigarettes appear to be more addictive than nicotine gum, making it harder for vapers to kick the habit, a small-scale lab study has found.E-cigarettes reinforced nicotine addiction more than nicotine gum among y.

227
227
article thumbnail

When the sea moves inland: A global climate wake-up call from Bangladesh's Delta

Science Daily: Pharmacology News

As sea levels climb and weather grows more extreme, coastal regions everywhere are facing a creeping threat: salt. Salinization of freshwater and soils adversely affects 500 million people around the world, especially in low-lying river deltas. A new study sheds light on how rising oceans are pushing saltwater into freshwater rivers and underground water sources in the world's largest river mouth -- the Bengal Delta in Bangladesh.

262
262
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

New AI Can Help Track Eczema

Drugs.com

FRIDAY, May 23, 2025 -- Eczema sufferers could soon find it easier to track their skin condition, via a newly developed AI that can assess severity using uploaded smartphone images.The AI demonstrated high diagnostic accuracy in evaluating eczema.

226
226
article thumbnail

'Hopelessly attached': Scientists discover new 2D material that sticks the landing

Science Daily: Pharmacology News

Researchers have discovered a new 2D material, confirming decade-old prediction.

Research 246
article thumbnail

Cities Contribute To Asthma, Researchers Argue

Drugs.com

FRIDAY, May 23, 2025 Dirty, crowded urban environments can significantly increase a persons risk of developing asthma, a new study says.Cleaner, better-thought-out cities could ward off 1 of every 10 asthma cases, researchers reported recently in.

Research 130
article thumbnail

Why are some rocks on the moon highly magnetic?

Science Daily: Pharmacology News

Scientists may have solved the mystery of why the moon shows ancient signs of magnetism although it has no magnetic field today. An impact, such as from a large asteroid, could have generated a cloud of ionized particles that briefly enveloped the moon and amplified its weak magnetic field.

230
230
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Design and Synthesized 3,4‐Dimethoxybenzene‐Based Fibrate Derivatives as Potential Hypolipidemic and Liver Protection Agents

Chemical Biology and Drug Design

The natural compounds berberine, cryptopine, phillygenin, and dimethylmatairesinol exhibit notable antioxidant and anti-inflammatory properties, closely associated with the 3,4-dimethoxybenzene structure within them. By leveraging the molecular hybridization principle based on the scaffold of fibrate lipid-lowering drugs, we have designed fibrate derivatives centered on 3,4-dimethoxybenzene.

article thumbnail

Elfucose

New Drug Approvals

Elfucose Cas 87-96-7 Chemical Formula: C6H12O5 Exact Mass: 164.07 Molecular Weight: 164.157 L-fucopyranose (6-deoxy-L-galactopyranose) (3 S ,4 R ,5 S ,6 S )-6-methyloxane-2,3,4,5-tetrol 6-Deoxy-L-galactose (ACI) Fucose, L- (8CI) (-)-Fucose 46: PN: US20220380460 SEQID: 47 claimed sequence 6-Desoxygalactose L-(-)-Fucose L-Fucose L-Galactomethylose L-Galactopyranose, 6-deoxy- CERC 803 Elfucose Fucose NSC 1219 congenital glycosylation disorders 6-Deoxy-L-galactopyranose L-galactomethylose 87-96-7 Fu

article thumbnail

Structural Insights Into Papain‐Derived Synthetic Antibacterial Peptides for Targeting Klebsiella pneumoniae

Chemical Biology and Drug Design

The synthetic peptides WK-MAP1 and WG-MAP2, bioinspired by papain, demonstrated optimized activity, particularly against multidrug-resistant Klebsiella pneumoniae , with improved sequence interaction profiles, membrane affinity, and predicted antimicrobial and antibiofilm efficacy, supporting their potential as therapeutic peptide candidates. ABSTRACT Bacterial resistance represents one of the greatest challenges in modern medicine, requiring innovative strategies.

Therapies 100
article thumbnail

Durlobactam

New Drug Approvals

Durlobactam CAS 1467829-71-5 WeightAverage: 277.25 Monoisotopic: 277.03685626 Chemical FormulaC 8 H 11 N 3 O 6 S Ingredient UNII CAS InChI Key Durlobactam sodium F78MDZ9CW9 1467157-21-6 WHHNOICWPZIYKI-IBTYICNHSA-M FDA 5/23/2023, Xacduro , To treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex Press Release Drug Trials Snapshots (2S,5R)-2-CARBAMOYL-3-METHYL-7-OXO-1,6-DIAZABICYCLO(

FDA 62
article thumbnail

Loading JSON Data into Snowflake From Local Directory

Perficient: Drug Development

In todays world, there are various data formats such as traditional, unstructured, raw format and semi structured data and load into target system. Semi structured data is often used in web applications, IOT and API sensors. Customers use JSON format mostly to get the data because it is easy to understand. Snowflake Snowflake is a cloud data warehouse that helps to load different data types and format of data.

article thumbnail

Balancing Efficacy and Cognitive Health In Bladder Assays

Reprocell

Overactive bladder (OAB) is a chronic and disabling condition that affects millions of people worldwide, significantly impacting physical, psychological, and social well-being. An estimated 183 million people worldwide suffer from overactive bladder, highlighting its global prevalence. 1 While OAB is more common in older adults, it can also affect younger individuals.

52
article thumbnail

Want To Live Longer? Stay Sociable, Study Says

Drugs.com

FRIDAY, May 23, 2025 Seniors who stay socially engaged are much more likely to have longer lives, a new study says.Social engagement among seniors is associated with a lower risk of death, when compared to seniors who are loners, according to f.

147
147
article thumbnail

Alcohol-Related Cancer Deaths Double In The U.S.

Drugs.com

FRIDAY, May 23, 2025 Alcohol-fueled cancer deaths nearly doubled in the United States during the past three decades, with cases among men driving this surge, a new study says.Between 1990 and 2021, deaths from alcohol-related cancers leaped from j.

173
173
article thumbnail

Biden’s Prostate Cancer Likely Grew Undetected for Years, Experts Say

Drugs.com

FRIDAY, May 23, 2025 Former President Joe Biden's prostate cancer diagnosis has drawn attention to screening guidelines for older men. When Biden, 82, was diagnosed last week, his cancer had already spread to his bones. His last prostate s.

239
239